Vaccines | Tenderlake

Vaccines

Contract Value:
EUR 300K - 300K
Notice Type:
Contract award notice
Published Date:
06 October 2023
Closing Date:
Location(s):
FI SUOMI / FINLAND (FI Finland/SUOMI / FINLAND)
Description:
Meningococcal Group B Vaccine 2024-2025 (2026, 2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested tenders for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.

The purpose of STM and the Customer was to procure Meningococcal Group B Vaccine required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for adults, children and infants.

More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:

https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/meningococcal-vaccines/meningococcus-b-vaccine

The Customer will implement the procurement on behalf of STM.

Awarded to:
Meningococcal Group B Vaccine 2024-2025 (2026, 2027)
GlaxoSmithKline Oy, Helsinki (FI)
Download full details as .pdf
The Buyer:
Ministry of Social Affairs and Health
CPV Code(s):
33600000 - Pharmaceutical products
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33651600 - Vaccines